Menu Back toSession-9-Track-2A-Scientific-Communication-Strategy

Medical Affairs and Scientific Communications Forum

Medical Communication, MSL, and Medical Writing.


Session 9 Track 2A: Scientific Communication Strategy

    Session Chair(s)
      David B. Clemow, PhD

      David B. Clemow, PhD

      • Advisor, Scientific Communications Information Strategy
      • Eli Lilly and Company, United States
    This session will provide insights and best practices for creating and organizing consistent messaging across regulatory submission and publication documents, with a focus on mapping clinical trial data outputs to key messages and downstream disclosure documents. The role of scientific communications (medical writing) in medical key message development, knowledge management, and dissemination will be discussed, with suggestions for process integration with other medical functions to aid with synergy. These topics will also be reviewed more holistically regarding the overall role of medical writers involvement in scientific communications strategy, based upon insights from the DIA Medical Writing Competency Model.
    Learning Objective : At the conclusion of this session, participants should be able to:
  • Apply and map clinical trial data outputs and related key messages from target profile through regulatory submission documents and publication disclosures
  • Define the role of scientific communications in medical key message development, knowledge management, and dissemination related to cross-functional partners
  • Explain the involvement of the medical writer role in scientific communications strategy
Speaker(s)
    David H Brown, MA, MSc

    Submission Communication Strategy Document to Drive Consistent Messaging in CTD Dossiers

    David H Brown, MA, MSc

    • Associate Director, Medical Communications Science
    • AstraZeneca Pharmaceuticals LP, United States
    David B. Clemow, PhD

    Medical and Scientific Key Message Development, Knowledge Management, and Dissemination

    David B. Clemow, PhD

    • Advisor, Scientific Communications Information Strategy
    • Eli Lilly and Company, United States
    Michael  Bourque, MS

    Medical Writing Leadership in Scientific Communications Strategy

    Michael Bourque, MS

    • Director of Global Submissions
    • Synchrogenix, a Certara Company, United States